NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Epoqe Pharma

Epoqe Pharma

Private
CopenhagenHealthcare & Life Scienceshttps://epoqepharma.com/

Last Round

Seed

Jan 28, 2025

Total Funding Raised

$13.93M

Company Overview

Epoqe Pharma is a biopharmaceutical company that develops novel peptide-based treatments for cardiovascular diseases, with a primary focus on Acute Myocardial Infarct (AMI).

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

peptide therapeuticsacute myocardial infarctionAMIfirst-in-class drugcardiovascular diseaseheart attack therapyCGRPpreclinical pharmadrug discoveryinfarct size reductioncalcitonin gene-related peptidebiopharmaceuticaldrug licensingmyocardial perfusion

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Epoqe Pharma Comparables

Compare Epoqe Pharma with similar companies based on industry and business-model similarity.

Epoqe Pharma comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Epoqe Pharma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJan 28, 2025
Series AJan 1, 2025
GrantJul 7, 2023

Key People

Founding team and executive leadership

Anette Sams

Chief Executive Officer and co-founder

Founding Team

Epoqe Pharma Investors

Notable investors and investment history

Epoqe Pharma investors
InvestorRounds
Lundbeck FoundationGrant
Innovation Fund DenmarkGrant
Lundbeckfonden BioCapitalSeries A, Seed
Sofinnova PartnersSeries A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 23, 2026

    Grew 400% QoQ from 1 to 5 employees.

  • Nov 8, 2025

    Monthly visitors grew 104% MoM, reaching 784.

Epoqe Pharma Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Epoqe Pharma Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Epoqe Pharma's valuation, stock price, and market status.

Firmographic Details

HeadquartersCopenhagen
Employee Range5
Year Founded2021
Last FundingJan 28, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.